COVID-19

How eye care practices and doctors can prepare for the next pandemic

A look back on what happened in optometry during the week of March 20-March 24.

Self-reported survey data “showed that a majority reported reductions in visual recognition and navigation abilities,” the researchers reported.

The eye care community is moving toward a more disruption-resistant system of care, from wearable tech to VEGF-eluting implants.

As 2022 comes to a close, check out some of the hottest and most-liked stories from the year!

The jury is still out on whether wearing glasses is associated with a decreased risk of COVID-19 infections.

These new testing kits permit more equitable access to coronavirus testing.

Japanese researchers conducted a systematic review that identified clinical features and host factors associated with corneal allograft rejection after COVID-19 vaccination.

A recent study shows US adults with hearing and visual impairments have lower rates of vaccination for the coronavirus.

A new study has found that having a contact lens regimen makes a difference when removing coronavirus particles, as well as the type of lens care solution that is used.

Researchers in Poland investigated the presence and duration of ocular symptoms of patients with symptomatic COVID-19 infections.

Researchers report that the incidence of retinal vein occlusions increased in the 6 months following COVID-19 diagnosis.

Researchers found that patients with nAMD lost vision as a result of the lockdown and reduced number of treatments during the COVID-19 pandemic.

Fully recovered COVID-19 patients have a higher prevalence for developing dry eye disease, researchers report.

At-home visual acuity tests compare favorably within 1 line of vision to VA measurements performed during a standard office visit.

Vascular density might be a biomarker for microvascular abnormalities following COVID-19

Acute infection did not impact the ability to obtain reliable test results

These habits wreak havoc on your vision

OCT showed inner retinal hyperreflectivity, diffuse retinal thickening with intraretinal fluid, and a serous macular detachment.

SARS-CoV-2 may target lacrimal gland tissue and manifest as chronic inflammation

The future is sustained-release injectables

Israeli researchers find a second booster shot was especially effective in individuals over 60 years of age, and “made them three times more resistant to serious illness."